ARS Pharmaceuticals Inc — Cash Flow (NASDAQ:SPRY) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 66.76 M40.08 M59.27 M13.55 M 112.47 M Cash from investing activities 66.48 M199 K87.18 M106.1 M 134.41 M Cash from financing activities 614 K190.73 M6.9 M72.4 M 174.38 M Free cash flow 65.39 M39.88 M59.09 M12.98 M 111.83 M

뉴스

ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)

What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)

Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)

중국, 최초 지역사회 사용 에피네프린 비강 스프레이 승인

China approves first community use epinephrine nasal spray for allergies

ARS 파마 CBO 착마, 147만 달러 상당 주식 매도

도르시, ARS 파마 COO, SPRY 주식 19만 달러 매도

ARS Pharma CBO Chakma sells shares worth $1.47 million

Dorsey, ARS Pharma COO, sells $190k in SPRY stock

ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript

ARS 파마슈티컬스, 3분기 매출 호조...Raymond James ’강력 매수’ 유지

윌리엄 블레어, ARS 파마슈티컬스 ’네피’ 데이터에 ’아웃퍼폼’ 등급 재확인